Huntington National Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $530K | Buy |
686
+44
| +7% | +$33.7K | ﹤0.01% | 621 |
|
|
2025
Q4 | $496K | Buy |
642
+112
| +21% | +$76.1K | ﹤0.01% | 553 |
|
|
2025
Q3 | $298K | Buy |
530
+152
| +40% | +$85.9K | ﹤0.01% | 672 |
|
|
2025
Q2 | $198K | Sell |
378
-122
| -24% | -$68.1K | ﹤0.01% | 747 |
|
|
2025
Q1 | $317K | Sell |
500
-419
| -46% | -$288K | ﹤0.01% | 612 |
|
|
2024
Q4 | $655K | Buy |
919
+314
| +52% | +$264K | ﹤0.01% | 464 |
|
|
2024
Q3 | $636K | Buy |
605
+33
| +6% | +$36.7K | ﹤0.01% | 475 |
|
|
2024
Q2 | $601K | Sell |
572
-80
| -12% | -$77.6K | ﹤0.01% | 466 |
|
|
2024
Q1 | $628K | Buy |
652
+174
| +36% | +$165K | 0.01% | 457 |
|
|
2023
Q4 | $420K | Buy |
478
+18
| +4% | +$14.8K | ﹤0.01% | 508 |
|
|
2023
Q3 | $379K | Sell |
460
-186
| -29% | -$146K | ﹤0.01% | 512 |
|
|
2023
Q2 | $464K | Sell |
646
-187
| -22% | -$144K | ﹤0.01% | 492 |
|
|
2023
Q1 | $684K | Sell |
833
-160
| -16% | -$121K | 0.01% | 431 |
|
|
2022
Q4 | $716K | Sell |
993
-82
| -8% | -$60.5K | 0.01% | 418 |
|
|
2022
Q3 | $740K | Sell |
1,075
-106
| -9% | -$66.7K | 0.01% | 403 |
|
|
2022
Q2 | $698K | Sell |
1,181
-424
| -26% | -$276K | 0.01% | 419 |
|
|
2022
Q1 | $1.12M | Sell |
1,605
-53
| -3% | -$33.5K | 0.01% | 376 |
|
|
2021
Q4 | $1.05M | Buy |
1,658
+8
| +0.5% | +$4.92K | 0.01% | 387 |
|
|
2021
Q3 | $998K | Buy |
1,650
+80
| +5% | +$49.7K | 0.01% | 384 |
|
|
2021
Q2 | $877K | Buy |
1,570
+713
| +83% | +$361K | 0.01% | 391 |
|
|
2021
Q1 | $405K | Buy |
857
+68
| +9% | +$33.1K | ﹤0.01% | 427 |
|
|
2020
Q4 | $381K | Buy |
789
+75
| +11% | +$40.5K | 0.01% | 413 |
|
|
2020
Q3 | $400K | Buy |
714
+248
| +53% | +$150K | 0.01% | 399 |
|
|
2020
Q2 | $291K | Sell |
466
-46
| -9% | -$26.1K | ﹤0.01% | 433 |
|
|
2020
Q1 | $250K | Buy |
512
+69
| +16% | +$28.5K | ﹤0.01% | 444 |
|
|
2019
Q4 | $166K | Sell |
443
-150
| -25% | -$50.5K | ﹤0.01% | 583 |
|
|
2019
Q3 | $164K | Sell |
593
-720
| -55% | -$213K | ﹤0.01% | 542 |
|
|
2019
Q2 | $411K | Sell |
1,313
-1,416
| -52% | -$471K | 0.01% | 410 |
|
|
2019
Q1 | $1.12M | Sell |
2,729
-904
| -25% | -$372K | 0.02% | 305 |
|
|
2018
Q4 | $1.36M | Sell |
3,633
-1,294
| -26% | -$474K | 0.02% | 289 |
|
|
2018
Q3 | $1.99M | Sell |
4,927
-2,959
| -38% | -$1.13M | 0.03% | 275 |
|
|
2018
Q2 | $2.72M | Sell |
7,886
-16,422
| -68% | -$5.14M | 0.05% | 253 |
|
|
2018
Q1 | $8.37M | Buy |
24,308
+24,192
| +20,855% | +$8.41M | 0.14% | 160 |
|
|
2017
Q4 | $44K | Sell |
116
-23
| -17% | -$9.31K | ﹤0.01% | 1013 |
|
|
2017
Q3 | $62K | Buy |
139
+105
| +309% | +$50K | ﹤0.01% | 917 |
|
|
2017
Q2 | $17K | Hold |
34
| – | – | ﹤0.01% | 1199 |
|
|
2017
Q1 | $13K | Buy |
34
+31
| +1,033% | +$11.5K | ﹤0.01% | 1144 |
|
|
2016
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 1415 |
|
|
2016
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 1491 |
|
|
2016
Q2 | $1K | Sell |
3
-28
| -90% | -$10.8K | ﹤0.01% | 1455 |
|
|
2016
Q1 | $14K | Sell |
31
-7
| -18% | -$2.88K | ﹤0.01% | 1423 |
|
|
2015
Q4 | $21K | Hold |
38
| – | – | ﹤0.01% | 1217 |
|
|
2015
Q3 | $17K | Buy |
38
+7
| +23% | +$3.76K | ﹤0.01% | 1321 |
|
|
2015
Q2 | $16K | Hold |
31
| – | – | ﹤0.01% | 1417 |
|
|
2015
Q1 | $14K | Buy |
31
+20
| +182% | +$8.48K | ﹤0.01% | 1432 |
|
|
2014
Q4 | $5K | Buy |
+11
| New | +$4.33K | ﹤0.01% | 1544 |
|
|
2014
Q2 | – | Sell |
-1,530
| Closed | -$460K | – | 1092 |
|
|
2014
Q1 | $460K | Buy |
1,530
+1,366
| +833% | +$421K | 0.01% | 811 |
|
|
2013
Q4 | $45K | Buy |
164
+73
| +80% | +$21K | ﹤0.01% | 1125 |
|
|
2013
Q3 | $28K | Sell |
91
-25
| -22% | -$6.58K | ﹤0.01% | 1235 |
|
|
2013
Q2 | $26K | Buy |
+116
| New | +$27K | ﹤0.01% | 1229 |
|
Other funds holding REGN
VCM
N
Huntington National Bank's REGN Position: Q1 2026 in Review
Huntington National Bank increased its Regeneron Pharmaceuticals (REGN) stake by 6.9% in Q1 2026, buying an estimated $33.7K and bringing the position to 686 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #621.
Huntington National Bank first reported a position in REGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $8.37M in Q1 2018. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Huntington National Bank held 686 shares of Regeneron Pharmaceuticals worth $530K as of Q1 2026.
- Huntington National Bank bought 44 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $33.7K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #621 holding.
- Huntington National Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Huntington National Bank's Regeneron Pharmaceuticals position peaked at $8.37M in Q1 2018.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.